Live feed20:32:09·289dINSIDERFilingvia QuantisnowChief R&D Officer Zalevsky Jonathan sold $57,693 worth of shares (1,721 units at $33.52), decreasing direct ownership by 9% to 17,462 units (SEC Form 4)ByQuantisnow·Wall Street's wire, on your screen.NKTR· Nektar TherapeuticsHealth CareOriginal source
